Inhibition of LPS-induced nitric oxide and TNF-α production by α-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages

Immunology and Cell Biology

Volumn 80, Issue 6, 2002, Pages 550-557

  Kiemer, Alexandra K ^a   Müller, Christian ^a   Vollmar, Angelika M ^a  

^a Center of Drug Research   (Germany)

Author keywords

Activator protein 1; Antioxidant; Inflammation; Liver; Nuclear factor B; Transcription factors

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SYNAPSIN I; THIOCTIC ACID; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; CELL ACTIVATION; CELL ISOLATION; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; KUPFFER CELL; LIVER PROTECTION; MACROPHAGE; MALE; MITOCHONDRION; NONHUMAN; RAT; RAT STRAIN; REDUCTION; REGULATORY MECHANISM; ANIMAL; ENZYME INDUCTION; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; MURINAE;

ANIMALS; ENZYME INDUCTION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036431462     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2002.01124.x     Document Type: Article

References (43)

1. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 1997; 29: 315-31.
2. Morikawa T, Yasuno R, Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 2001; 498: 16-21.
3. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 1995; 19: 227-50.
4. Cameron NE, Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 1999; 45: 137-46.
5. Biewenga G, Haenen GR, Bast A. The role of lipoic acid in the treatment of diabetic polyneuropathy. Drug Metab. Rev. 1997; 29: 1025-54.
6. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 1998; 24: 1023-39.
7. Bludovska M, Kotyzova D, Koutensky J, Eybl V. The influence of alpha-lipoic acid on the toxicity of cadmium. Gen. Physiol. Biophys. 1999; 18: 28-32.
8. Marley R, Holt S, Fernando B et al. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 1999; 29: 1358-63.
9. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 1990; 192: 245-61.
10. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 1991; 138: 395-402.
11. Gandhi CR, Stephenson K, Olson MS. A comparative study of endothelin- and platelet-activating-factor mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem. J. 1992; 281: 485-92.
12. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 2001; 107: 439-47.
13. Ring A, Stremmel W. The hepatic microvascular responses to sepsis. Semin. Thromb. Hemost. 2000; 26: 589-94.
14. Förstermann U, Kleinert H. Nitric oxide synthase: Expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 1995; 352: 351-64.
15. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv. Pharmacol. 1995; 34: 155-70.
16. Garcia-Monzon C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J. Hepatol. 2000; 32: 331-8.
17. Ahn B, Han BS, Kim DJ, Ohshima H. Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine. Carcinogenesis 1999; 20: 1337-44.
18. Rahman MA, Dhar DK, Yamaguchi E et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: Possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin. Cancer Res. 2001; 7: 1325-32.
19. Suzuki S, Nakamura S, Serizawa A et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24: 219-25.
20. Hussain MJ, Lau JY, Williams R, Vergani D. Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. J. Clin. Pathol. 1994; 47: 1112-15.
21. van PT, Lowry SF. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 1995; 3: 1-12.
22. Shibuya H, Ohkohchi N, Tsukamoto S, Satomi S. Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology 1997; 26: 113-20.
23. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 1998; 275: G387-92.
24. Kiemer AK, Baron A, Gerbes AL, Bilzer M, Vollmar AM. The atrial natriuretic peptide as a regulator of Kupffer cell functions. Shock 2002; 17: 365-71.
25. Collier DS, Pain JA, Wight DG, Lovat P, Bailey ME. The Kupffer cell in experimental extrahepatic cholestasis in the rat - A light microscopy, immunohistochemical and electron microscopy study. J. Pathol. 1986; 150: 187-94.
26. Kiemer AK, Vollmar AM. Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide. Immunol. Cell Biol. 2001; 79: 11-17.
27. Kiemer AK, Vollmar AM. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology 1997; 138: 4282-90.
28. Kiemer AK, Hartung T, Vollmar AM. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J. Immunol. 2000; 165: 175-81.
29. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994; 269: 4705-8.
30. Kristof AS, Marks-Konczalik J, Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 2001; 276: 8445-52.
31. Rhoades KL, Golub SH, Economou JS. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 1992; 267: 22102-7.
32. Roy S, Sen CK, Kobuchi H, Packer L. Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radic. Biol. Med. 1998; 25: 229-41.
33. Peter G, Borbe HO. Absorption of [7,8-14C]rac-a-lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat. Arzneimittelforschung 1995; 45: 293-9.
34. Guo Q, Tirosh O, Packer L. Inhibitory effect of alpha-lipoic acid and its positively charged amide analogue on nitric oxide production in RAW 264.7 macrophages. Biochem. Pharmacol. 2001; 61: 547-54.
35. Liang JF, Akaike T. Inhibition of nitric oxide synthesis in primary cultured mouse hepatocytes by alpha-lipoic acid. Chem. Biol. Interact. 2000; 124: 53-60.
36. Bierhaus A, Chevion S, Chevion M et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481-90.
37. Suzuki YJ, Aggarwal BB, Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 1992; 189: 1709-15.
38. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001; 107: 135-42.
39. Saliou C, Kitazawa M, McLaughlin L et al. Antioxidants modulate acute solar ultraviolet radiation-induced NF- kappa-B activation in a human keratinocyte cell line. Free Radic. Biol. Med. 1999; 26: 174-83.
40. van BR, van den Haenen GRBH, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 2001; 86: S121-S127.
41. Lee HA, Hughes DA. Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA. Exp. Gerontol. 2002; 37: 401-10.
42. Mizuno M, Packer L. Effects of alpha-lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos. Biochem. Biophys. Res. Commun. 1994; 200: 1136-42.
43. Rizzardini M, Zappone M, Villa P et al. Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: Role of interleukin 1beta. Hepatology 1998; 27: 703-10.